SYS-CON MEDIA Authors: Jason Bloomberg, Kevin Benedict, David H Deans, RealWire News Distribution, Gilad Parann-Nissany

News Feed Item

Concise Analysis of the International Chinese Patent Medicine Industry

DUBLIN, March 18, 2014 /PRNewswire/ --

Research  and  Markets (http://www.researchandmarkets.com/research/wlrph9/china_patent) has announced the addition of the "Concise Analysis of the International Chinese Patent Medicine Industry" report to their offering. 

Chinese patent medicine refers to the certain dosage forms of medicine, under the guidance of TCM (traditional Chinese medicine) theory, made from traditional Chinese medicinal materials in accordance with specified prescription and standard. Chinese patent medicine industry covers the upstream Chinese herbal medicine production and preliminary processing, the middle pharmaceutical sectors as well as downstream commercial institutions of drug circulation and sales.

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769 )


Currently, the State is enhancing its support for the Chinese patent medicine industry, successively introducing the Continuing Improving TCM Healthcare Policy, Notice on Conducting Construction of Key Projects of TCM Trade in Services and other favorable policies in 2013. In 2010-2013, China's Chinese patent medicine industry developed rapidly, with revenue soaring from RMB215.4 billion to RMB448.2 billion at a CAGR of 27.7%. 

According to hospital terminal data, Chinese patent medicine for the treatment of cardiovascular and cerebrovascular diseases, tumor diseases and respiratory system diseases are the top three categories of Chinese patent medicine in China, respectively accounting for 37.2%, 15.4% and 11.1% market share in 2012-2013. As far as the distribution of Chinese patent medicine formulations is concerned, there is a clear trend of convergence in injection, and injection formulation products in the top three categories of Chinese patent medicine all made up above 50%.

Cardiovascular and cerebrovascular disease market is the biggest market for Chinese patent medicine, but also the most-variety field with item sales of over RMB500 million


Key  Topics  Covered: 

1. Overview of Chinese Patent Medicine

2. Operating Environment for Chinese Patent Medicine Industry

3. Chinese Patent Medicine Market

4. Chinese Patent Medicine Market Segments in China

5. Key Enterprises

6. Summary and Forecast


Companies  Mentioned:

  • Beijing Tongrentang
  • China Resources Sanjiu Medical & Pharmaceutical
  • Guizhou Yibai Pharmaceutical
  • Kangmei Pharmaceutical
  • Shandong Dong-E E-Jiao
  • Shanghai Kaibao Pharmaceutical
  • Tianjin Tasly Pharmaceutical
  • Tibet Rhodiola Pharmaceutical Holding
  • Yunnan Baiyao Group
  • Zhangzhou Pientzehuang Pharmaceutical


For more information visit http://www.researchandmarkets.com/research/wlrph9/china_patent


Media  Contact: Laura Wood , +353-1-481-1716, [email protected]


SOURCE Research and Markets

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.